A year into the pandemic response, pharmacy leaders know to expect the unexpected.
The day-to-day challenges often take us beyond the guardrails of compliance and slow progress towards best practice. In this webinar, join Wolters Kluwer compliance expert Annie Lambert, PharmD, BCSCP to discuss some key points of focus to help you maintain your balance in the unsteady world of COVID-19, interim guidance, and the impacts to your compounding practice.
You will learn:
- Key criteria of USP and FDA interim compounding guidance to ensure compliance.
- The impacts of interim guidance and COVID-19 to pharmacy operations and strategies to mitigate them.
- Best practices in sterile and HD compounding oversight to ensure your site is inspection-ready in a pandemic world.